KIP SOVIAK: Open Payments
NPI 1063147445 · FREMONT, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,512 in 93 payments from 20 companies in 2025. Trend: 2023 $963 · 2024 $1,460 · 2025 $1,512
Food & beverage: $1,429Education: $84
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 29 | $369 |
| Teva Pharmaceuticals USA, Inc. | 20 | $324 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 11 | $188 |
| Otsuka America Pharmaceutical, Inc. | 5 | $110 |
| E.R. Squibb & Sons, L.L.C. | 4 | $70 |
| Alkermes, Inc. | 3 | $54 |
| Vanda Pharmaceuticals Inc. | 2 | $53 |
| Axsome Therapeutics, Inc. | 2 | $43 |
| Neurocrine BioSciences, Inc. | 2 | $39 |
| AstraZeneca Pharmaceuticals LP | 2 | $39 |
Products named: VRAYLAR, CAPLYTA, AUSTEDO XR, UZEDY, COBENFY, ABILIFY MAINTENA, FANAPT, REXULTI.
Industry payments across OH — which companies pay providers there.
